ENDEFR
Home › United States › JUNO THERAPEUTICS, INC.

JUNO THERAPEUTICS, INC.

Corporation · WILMINGTON, United States · LEI 5493004CAOW3ZGG2CV25
LEI active

Summary

JUNO THERAPEUTICS, INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is BRISTOL-MYERS SQUIBB COMPANY (United States), and its direct parent is CELGENE CORPORATION (United States). That group has 26 subsidiaries with LEIs in 17 countries, 5 of them in the United States. The LEI was first issued on 4 Nov 2014 and the record was last updated on 10 Feb 2026; the next renewal is due by 11 Feb 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formCorporation
Register · Register website
Registration number5378373
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 19801 WILMINGTON, United States
Headquarters address400 Dexter Avenue North, 98109 Seattle, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)5 Aug 2013
LEI5493004CAOW3ZGG2CV25
LEI statusactive
LEI first issued4 Nov 2014
LEI record last updated10 Feb 2026
Next LEI renewal11 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

BRISTOL-MYERS SQUIBB COMPANY United States ultimate parent
CELGENE CORPORATION United States lapsed direct parent
JUNO THERAPEUTICS, INC. this entity
View the whole group: 26 subsidiaries in 17 countries

Relationship to the parent

Direct parentUltimate parent
ParentCELGENE CORPORATIONBRISTOL-MYERS SQUIBB COMPANY
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start5 Aug 201327 Jan 2021
Recorded at GLEIF since5 Jun 202419 Jun 2012
Last updated10 Feb 202510 Feb 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (2)

ISINs mapped to this LEI (1)

US48205A1097

1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.